各位作者、审稿专家:
本刊官方微信服务号新增稿件状态查询服务,无需反复登录投稿系统,微信即可随时查看审稿进度、修回通知、录用结果,稿件更新实时推送提醒,同步接收期刊征稿、学术资讯。
微信搜索关注广州医药杂志服务号 → 点击菜单栏「绑定账号」→ 输入投稿邮箱完成账号关联;请关闭微信消息免打扰,避免遗漏稿件通知。
《广州医药》编辑部
目的 观察手指点穴结合利水消散包外敷对癌性腹水的疗效。方法 选择我科收治的癌性腹水患者60例为研究对象,随机分为对照组和治疗组各30例。对照组常规限水、限钠、利尿护理,治疗组在常规护理的基础上,实施手指点穴结合利水消散包外敷腹部,7天为1疗程,共干预3个疗程后进行疗效评价,观察两组患者治疗前后体质量、腹围变化、生活质量评分(KPS)。结果 治疗组总有效率为86.66%,对照组为56.67%,治疗组临床疗效优于对照组(P<0.05),两组治疗后平均体质量、腹围均比本组治疗前降低,且治疗组治疗前后差值大于对照组(P<0.05),治疗组治疗后KPS评分也高于对照组(P<0.05)。结论 手指点穴结合利水消散包外敷对癌性腹水有减轻疗效,能改善患者生活质量,操作简单,成本低,易被患者接受,适宜在临床应用。
Objective To observe the efficacy of finger-pointing combined with the dispersal package of outer application of the water to cancerous ascites. Methods 60 patients with cancerous ascites were selected as study subjects, randomly divided into treatment group and control group, with 30 cases each. The control group of patients using conventional water limit, sodium limit, diuretic car,in treatment group, on the basis of conventional care, the implementation of finger-pointing combined with water dissipation package outside the abdoment was take.We took the navel as the center,7 days for 1 course of treatment.After a total of 3 courses of intervention, the efficacy evaluation was carried out, to observe the two groups of patients before and after treatment in weights, abdominal circumference changes, qualities of life score (KPS). Results The total efficiency treatment group was 86.66%, the control group was 56.67%, the clinical efficacy of the treatment group was better than that of the control group (P <0.05), the average weight and abdominal circumference were lower after treatment in both groups than before treatment, and the difference between treatment group before and after treatment was greater than that of the control group (P <0.05), and the KPS score after treatment group was also higher than that of the control group (P<0.05). Conclusion Finger point slot combination with the ex-envelope of water dissipation has reduced the effect of cancerous ascites, can improve the quality of life of patients, simple operation, low cost, easy to be accepted by patients, suitable for clinical application.
目的 探讨腹腔镜下卵巢癌减灭术联合化疗治疗卵巢癌的疗效。方法 选取2018年2月—2020年2月我院收治的68例卵巢癌患者,随机分为研究组和对照组各34例,对照组给予腹腔镜下卵巢癌减灭术,研究组给予腹腔镜下卵巢癌减灭术联合化疗。观察分析两组患者近期疗效、不良反应发生率、生存率以及相关手术情况等。结果 研究组近期疗效优于对照组(P<0.05);研究组术后1年生存率高于对照组(P<0.05),且并发症发生率低于对照组(P<0.05);研究组理想减灭率优于对照组(P<0.05),且腹水量及术中出血量少于对照组(P<0.05),手术时间短于对照组(P<0.05)。结论 减灭术联合化疗治疗卵巢癌可有效增强治疗疗效,降低多种化疗不良反应发生的可能性,并能使生存率得到进一步提升,可推广应用。
Objective To investigate the efficacy of laparoscopic ovarian cancer reduction combined with chemotherapy in the treatment of ovarian cancer. Methods A total of 68 ovarian cancer patients admitted to our hospital from February 2018 to February 2020 were randomly divided into study group and control group, 34 cases each. The control group was given laparoscopic ovarian cancer reduction surgery, while the study group was given laparoscopic ovarian cancer reduction surgery combined with chemotherapy. The short-term efficacy, incidence of adverse reactions, survival rate and related operation of the two groups were observed and analyzed. Results The short-term efficacy of the study group was better than that of the control group (P<0.05). The 1-year postoperative survival rate of the study group was higher than that of the control group (P<0.05), and the incidence of complications was lower than that of the control group (P<0.05). The ideal reduction rate of the study group was better than that of the control group (P<0.05), and the amount of abdominal water and intraoperative blood loss was less than that of the control group (P<0.05), and the operation time was shorter than that of the control group (P<0.05). Conclusion Laparoscopic ovarian cancer reduction combined with chemotherapy can effectively enhance the therapeutic effect, reduce the possibility of multiple adverse reactions of chemotherapy, and further improve the survival rate, which can be popularized and applied.
目的 探讨玻璃体切除术联合玻璃体腔注射曲安奈德治疗特发性黄斑前膜患者疗效观察。方法 选取我院2018年1月—2020年1月特发性黄斑前膜(idiopathic macular epiretinal membrane, IMEM)患者38例。随机分为治疗组(18例,18眼)与对照组(20例,20眼)。治疗组在术中予以玻璃体切除联合黄斑前膜剥除及内界膜剥除术,并注入曲安奈德(triamcinolone acetonide,TA),对照组术中单纯行玻璃体切除联合黄斑前膜剥除及内界膜剥除术。比较两组患者手术前及手术后1月、3月、6月的最佳矫正视力(BCVA)及黄斑中心凹厚度数值(CMT)及房水白细胞介素-6(IL-6)的变化情况。结果 术中所有患者成功剥除黄斑前膜,术后所有患者均未出现玻璃体积血、视网膜脉络膜脱离及眼压增高等并发症。两组患者中,所有患者手术后BCVA均较手术前有所提高,且治疗组优于对照组,差异有统计学意义(P<0.05)。手术后治疗组CMT下降幅度优于对照组,差异有统计学意义(P<0.05)。手术后治疗组房水中IL-6水平明显低于对照组,差异有统计学意义(P<0.05)。结论 玻璃体切割及内界膜剥除术联合玻璃体腔内注射TA治疗IMEM,有助于提高患者术后视力,降低患者黄斑中心凹厚度,减轻患者黄斑水肿程度,减少房水中白细胞介素-6的表达。
目的 研究鼻内镜下应用低温等离子高选择性翼管神经分支切断治疗变应性鼻炎患者的临床疗效。方法 选取我院2019年1月—2020年12月收治的60例变应性鼻炎患者,随机数字表法分为对照组(30例)和观察组(30例)。对照组行保守治疗,观察组行鼻内镜下低温等离子高选择性翼管神经分支切断术治疗。比较两组治疗前后Lund—Kennedy内镜黏膜形态评分、视觉模拟量表(VAS)评分,分析两组治疗前后炎症细胞因子[血清肿瘤坏死因子-α(TNF-α)、白介素-4(IL-4)、白介素-6(IL-6)]及鼻黏膜功能指标[血管活性常态肠肽(VIP)、鼻腔阻力(NR)、鼻黏膜纤毛传输时间(MTT)、鼻黏膜纤毛输送率(MTR)]变化情况。结果 两组治疗后VAS评分、Lund—Kennedy评分较治疗前降低(P<0.05);观察组治疗后VAS评分、Lund—Kennedy评分低于对照组(P<0.05)。两组治疗后TNF-α、IL-4、IL-6水平较治疗前降低(P<0.05);观察组治疗后TNF-α、IL-4、IL-6水平低于对照组(P<0.05)。两组治疗后VIP、NR、MTT水平较治疗前降低(P<0.05),MTR水平较治疗前升高(P<0.05);观察组治疗后VIP、NR、MTT水平低于对照组(P<0.05),MTR水平高于对照组(P<0.05)。结论 鼻内镜下应用低温等离子高选择性翼管神经分支切断术治疗变应性鼻炎疗效显著,可改善鼻腔黏膜功能,减轻炎症反应,值得推广。
目的 分析基底节区脑出血患者接受神经内镜手术治疗的疗效。方法 将2019年6月—2020年8月接诊且行开颅血肿清除术的33例基底节区脑出血患者作为对照组,将同期接诊且行神经内镜手术的33例基底节区脑出血患者作为观察组,对组间美国国立卫生研究院卒中量表(NIHSS)、独立功能量表(FIM)、日常生活能力(ADL)评分、手术情况、血清水通道蛋白4(AQP4)水平、脑水肿体积、并发症情况展开分析。结果 (1)组间NIHSS、FIM、ADL评分在术前无明显差异,P>0.05;术后,观察组NIHSS评分更低,且FIM、ADL评分更高,P<0.05;(2)观察组骨窗大小(2.53±0.66)cm、切口长度(4.22±0.67)cm、术中失血量(47.58±11.25)mL、手术用时(1.58±0.42)h均少于对照组(10.88±1.13)cm、(11.84±2.31)cm、(149.83±33.76)mL、(2.99±0.63)h,且血肿清除率(88.84±9.62)%大于对照组(75.31±7.24)%,P<0.05;(3)观察组术后1周、术后2周、术后1个月时的AQP4水平、脑水肿体积均小于对照组,P<0.05;(4)观察组发生1例并发症(3.03%),对照组发生7例并发症(21.21%),P<0.05。结论 对基底节区脑出血患者进行神经内镜手术治疗,手术创伤小,可以降低AQP4水平,减少脑水肿体积及并发症,提高生活能力,值得推广。
Objective To analyze the curative effect of neuroendoscopic surgery in patients with basal ganglia intracerebral hemorrhage. Methods From June 2019 to August 2020, 33 patients with basal ganglia intracerebral hemorrhage who received craniotomy and hematoma clearance were selected as the control group, and 33 patients with basal ganglia intracerebral hemorrhage who received neuroendoscopic surgery at the same period were selected as the observation group. NIHSS,FIM and ADL scores,details of the surgery, levels of AQP4, brain edema volume and complications were analyzed. Results (1) There were no significant differences in NIHSS, FIM and ADL scores between the two groups before operation, P>0.05; after operation, NIHSS score of the observation group was lower, and FIM and ADL scores were higher, P<0.05. (2) Bone window size of the observation group was (2.53±0.66) cm, incision length was (4.22±0.67) cm, intraoperative blood loss was (47.58±11.25) mL, and operation time was (1.58±0.42) h, which were less than those of the control group [(10.88±1.13) cm and (11.84±2.31) cm, (149.83±33.76) mL, (2.99±0.63) h], and the hematoma clearance rate (88.84±9.62)% was higher than that of the control group (75.31±7.24)%, P<0.05. (3) The AQP4 level and brain edema volume of the observation group 1 week, 2 weeks and 1 month after operation were lower than those of the control group, P<0.05. (4) There was one complication (3.03%) in the observation group and seven complications (21.21%) in the control group,P<0.05. Conclusion Neuroendoscopic surgery for patients with basal ganglia cerebral hemorrhage can reduce the level of AQP4, the volume of brain edema and complications, and improve the ability of life, which is worthy of promotion.
目的 探讨经子宫后路子宫修补术联合血管阻断治疗前置胎盘的临床效果,旨在为临床治疗提供参考依据。方法 回顾性分析2018年2月—2020年2月本院收治的86例前置胎盘患者临床资料,依据治疗方式不同分为实验组(n=50)与对照组(n=36),两组患者均开展子宫修补术,对照组增加低位腹主动脉球囊阻断术,实验组增加血管阻断治疗。对比两组患者非产科因素并发症率、围术期相关指标及新生儿结局。结果 实验组非产科因素并发症率低于对照组,差异有统计学意义(P<0.05);两组患者手术时间、住院时间、术中出血量、血浆输入量比较,差异无统计学意义(P>0.05);两组新生儿Apgar评分、窒息率及体质量比较,差异无统计学意义(P>0.05)。结论 前置胎盘患者在子宫后路子宫修补术基础上开展血管阻断进行干预,与低位腹主动脉球囊阻断术治疗效果差异性较小,但血管阻断治疗可避免X线对机体产生辐射,进而降低非产科因素并发症率,不良反应小,安全性较高,值得临床推广。
目的 观察早期经鼻肠内营养(ENEN)对中-重度急性胰腺炎(MSAP+SAP)患者的治疗效果。方法 回顾性分析2014年9月—2019年5月期间,广东药科大学附属第一医院消化内科收治的50例MSAP及SAP患者临床资料,根据患者营养支持治疗方式不同,将患者分为观察组(n=25)和对照组(n=25)。观察组患者采用ENEN治疗,对照组采用肠外肠内营养联合(PNEN)治疗。对比两组患者治疗后血清白蛋白(ALB)、血清前白蛋白(PA)、C-反应蛋白(CRP)、急性生理与慢性健康(APACHE Ⅱ)评分、序贯器官功能衰竭(SOFA)评分及多器官功能障碍综合征(MODS)发生率。结果 经过治疗后,观察组患者ALB水平、PA水平高于对照组,CRP水平低于对照组,差异有统计学意义(P<0.05)。经过治疗后,观察组患者APACHE Ⅱ评分、SOFA评分低于对照组,差异有统计学意义(P<0.05)。经过治疗后,观察组患者MODS发生率低于对照组,差异有统计学意义(P<0.05)。结论 ENEN治疗MSAP及SAP患者可有效改善患者营养状态和健康状况,降低机体炎症反应,减少MODS发生率。
Objective To observe the effect of early nasal enteral nutrition(ENEN) on patients with moderate to severe acute pancreatitis(MSAP+SAP). Methods A retrospective analysis of the clinical data of 58 patients with(MSAP+SAP) admitted to the department of gastroenterology, the First Affiliated Hospital of Guangdong Pharmaceutical University from September 2014 to May 2019, according to the different nutritional support treatment methods, the patients were divided into observation groups(n=25) and control group(n=25). Patients in the observation group were treated with ENEN, and the control group was treated with Parenteral nutrition and enteral nutrition(PNEN). Serum albumin(ALB), serum prealbumin(PA), C-reactive protein(CRP), acute physiology and chronic health evaluation(APACHE II) score, sequential organ failure assessment(SOFA) score, and incidence of multiple organ dysfunction syndrome(MODS) were compared between the two groups. Results After treatment, the ALB and PA level of the observation group were higher than those of the control group, and the CRP level was lower than that of the control group, the difference was statistically significant(P<0.05). After treatment, the APACHE II score and SOFA score of the observation group were lower than those of the control group, and the difference was statistically significant(P<0.05). After treatment, the incidence of MODS in the observation group was lower than that in the control group, and the difference was statistically significant(P<0.05). Conclusion ENEN treatment of MSAP and SAP may effectively improve the nutritional status and health of patients, reduce the body's inflammatory response and reduce the incidence of MODS.
目的 研究我院自拟肿痛消方中药离子导入联合关节镜手术治疗膝骨性关节炎的疗效。方法 将76 例膝骨性关节炎患者分为2组,即肿痛消方离子导入联合关节镜组和单纯关节镜组,在治疗前、后分别对两组患者进行Lysholm膝关节功能评分。结果 肿痛消方联合关节镜手术治疗对膝骨性关节炎的治疗效果有明显的提高,总有效率达到92.11%,高于对照组。结论 肿痛消方联合关节镜手术治疗对膝骨性关节炎具有良好的治疗效果。可明显降低患者的疼痛感,改善膝关节功能,促进骨关节的恢复。
Objective To study the effect of Zhongtongxiao formula combined with arthroscopy in the treatment of knee osteoarthritis. Methods 76 patients with knee osteoarthritis were divided into two groups, namely, the group of Zhongtongxiao square ion-implantation combined with arthroscopy and the group of arthroscopy alone. Lysholm knee function scores were performed on the two groups before and after treatment. Results The therapeutic effects of Zhongtongxiao formula combined with arthroscopic surgery on knee osteoarthritis were improved, the total effective rate was 92.11%, higher than the control group. Conclusion Zhongtongxiao formula combined with arthroscopy has good therapeutic effect on knee osteoarthritis.It can obviously reduce the pain of patients, improve the function of knee joint and promote the recovery of bone and joint.
目的 探讨运用李可老中医学术思想,从“中气”论治术后肠梗阻的疗效。方法 采用前瞻性临床观察队列研究方法,选择82例术后肠梗阻患者,按照随机化原则平均分为两组:观察组为西医治疗基础上,联合从“中气”论治应用方剂,对照组为单纯西医治疗。结果 观察组的有效率为95.12%,首次排气时间为(12.46±2.75)h,首次排便时间为(31.52±5.38)h,腹痛腹胀完全消失时间为(15.71±3.57)h,平均住院时间为(18.69±3.82)d;对照组的有效率为73.17%,首次排气时间为(36.57±2.75)h,首次排便时间为(62.39±5.73)h,腹痛腹胀完全消失时间为(42.58±8.27)h,平均住院时间为(25.95±5.84)d;有效率对比,观察组高于对照组(P<0.05),观察组症状改善时间较对照组明显缩短(P<0.05)。结论 对于术后肠梗阻的治疗,西医联合从“中气”论治疗效优于单纯西医治疗。
Objective To explore the therapeutic effect on postoperative ileus with Li Ke's academic thought of traditional Chinese medicine: by mediating the Qi in the middle energizer(Stomach and Spleen). Methods Using prospective clinical observation cohort study, 82 patients with postoperative ileus were randomly divided into two groups on average: the observation group was treated with Western medicine and Chinese medicine decoction in which prescribed by the principle of mediating the Qi in the middle energizer(stomach and spleen). while the control group was treated with Western medicine only. Results The effective rate of the observation group was 95.12%, the average time of first farting of the patients was(12.46±2.75) h, the average time of first defecation was (31.52±5.38)h, the average time of complete disappearance of abdominal pain and abdominal distension was (15.71±3.57) h, and the average hospital stays was (18.69±3.82) d. In the control group, the effective rate was 73.17%, the average time of first farting of the patients was (36.57±2.75)h, the average time of first defecation was (62.39±5.73)h, the average time of complete disappearance of abdominal pain and abdominal distension was (42.58±8.27)h, and the average hospital stays was (25.95±5.84)d. Compared with the control group, the effective rate was higher in the observation group (P <0.05), and the symptom improvement time in the observation group was shorter than that in the control group (P <0.05). Conclusion For the treatment of postoperative ileus, western medicine combined with Chinese medicine decoction in which prescribed by the principle of mediating the Qi in the middle energizer(stomach and spleen) is better than Western medicine only.
目的 探讨四金石灵膏联合间苯三酚治疗输尿管结石伴肾绞痛的应用价值。方法 随机将76例输尿管结石伴肾绞痛患者分为两组,以接受中药安慰剂联合间苯三酚治疗者为对照组,以接受四金石灵膏联合间苯三酚治疗者为观察组,每组38例。对比两组临床治疗效果,并分析尿液相关指标的变化情况。结果 两组7 d治疗过程中VAS评分及尿Ga水平呈降低趋势、WHOQL-BREF评分及尿OPN水平呈升高趋势(P<0.05),而治疗3 d及7 d后,治疗组VAS评分及尿Ga水平低于对照组、WHOQL-BREF评分及尿OPN水平高于对照组(P<0.05)。同时,治疗7 d后,观察组排石率高于对照组(P<0.05),而观察组排石时间及止痛时间短于对照组(P<0.05)。此外,治疗7 d后,治疗组治疗总有效率高于对照组(P<0.05),而两组间治疗不良反应发生率比较未见差异有统计学意义(P>0.05)。结论 四金石灵膏联合间苯三酚可有效的提高输尿管结石伴肾绞痛的临床治疗效果,具有较为理想的应用价值。
Objective To explore the application value of four-gold-stone-ling confection and phloroglucinol in the treatment of ureteral calculus with renal colic. Methods 76 patients with ureteral calculus with renal colic were randomly divided into two groups, with those receiving traditional Chinese medicine placebo combined with phloroglucinol as the control group, and those receiving four-gold-stone-ling confection combined with phloroglucinol as the observation group,38 cases in each group. The clinical treatment effects of the two groups were compared, and the changes of urine-related indicators were analyzed. Results The VAS score and urine Ga level of the two groups showed a decreasing trend during 7d treatment, and the WHOQL-BREF score and urine OPN level showed an increasing trend(P<0.05). After 3d and 7d treatment, the VAS score and urine Ga level of the treatment group were lower than that of control group, the WHOQL-BREF score and urine OPN level were higher than that of control group(P<0.05). Meanwhile, After 7d of treatment, the rate of stone drainage in the observation group was higher than that of control group(P<0.05), while the time of stone drainage and pain relief in the observation group was shorter than control group(P<0.05). In addition, after 7d treatment, the total effective rate of the treatment group was higher than control group (P<0.05), while the difference of incidence of adverse reactions between the two groups was not significant(P>0.05). Conclusion Four-gold-stone-ling confection combined with phloroglucinol may effectively improve the clinical effect of ureteral calculi with renal colic, and have ideal application value.